GENEVA, April 16 -- UNIVERSITEIT VAN AMSTERDAM (Spui 211012 WX Amsterdam) filed a patent application (PCT/NL2024/050536) for "REDUCING DOPAMINE FEED-BACK INHIBITION IN DOPAMINERGIC CELLS BY TADALAFIL." on Oct 02, 2024. With publication no. WO/2025/075499, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN DER HEIDE, Lars Philip (c/o Spui 211012 WX Amsterdam), SMIDT, Marten Piet (c/o Spui 211012 WX Amsterdam)

Abstract: The invention relates to dopamine, a dopamine agonist, L-DOPA or a prodrug thereof for use in a metho...